Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 708.08 Million SAR | 25.02% |
| 2022 | 566.32 Million SAR | -8.64% |
| 2021 | 619.86 Million SAR | -10.4% |
| 2020 | 691.81 Million SAR | 25.61% |
| 2019 | 550.74 Million SAR | -11.23% |
| 2018 | 620.4 Million SAR | -11.93% |
| 2017 | 704.46 Million SAR | -22.53% |
| 2016 | 909.38 Million SAR | 9.29% |
| 2015 | 832.1 Million SAR | 4.73% |
| 2014 | 794.53 Million SAR | 13.26% |
| 2013 | 701.52 Million SAR | 3.12% |
| 2012 | 680.31 Million SAR | 21.36% |
| 2011 | 560.56 Million SAR | 15.29% |
| 2010 | 486.22 Million SAR | 16.22% |
| 2009 | 418.37 Million SAR | 15.8% |
| 2008 | 361.28 Million SAR | 11.08% |
| 2007 | 325.23 Million SAR | 5.45% |
| 2006 | 308.41 Million SAR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 252 Million SAR | 147.06% |
| 2024 Q2 | 177.4 Million SAR | -29.6% |
| 2023 Q3 | 165.97 Million SAR | -9.54% |
| 2023 Q1 | 256.93 Million SAR | 87.19% |
| 2023 FY | 708 Million SAR | 25.02% |
| 2023 Q2 | 183.49 Million SAR | -28.58% |
| 2023 Q4 | 102 Million SAR | -38.55% |
| 2022 FY | 566.32 Million SAR | -8.64% |
| 2022 Q4 | 137.26 Million SAR | 11.36% |
| 2022 Q3 | 123.25 Million SAR | 1.84% |
| 2022 Q1 | 184.78 Million SAR | 17.03% |
| 2022 Q2 | 121.02 Million SAR | -34.5% |
| 2021 Q4 | 157.89 Million SAR | 8.06% |
| 2021 Q2 | 168.76 Million SAR | 18.61% |
| 2021 FY | 619.86 Million SAR | -10.4% |
| 2021 Q3 | 146.11 Million SAR | -13.42% |
| 2021 Q1 | 142.27 Million SAR | 10.67% |
| 2020 Q1 | -74.6 Million SAR | -163.83% |
| 2020 Q3 | 200.38 Million SAR | 1413.62% |
| 2020 FY | 691.81 Million SAR | 25.61% |
| 2020 Q4 | 128.56 Million SAR | -35.84% |
| 2020 Q2 | -15.25 Million SAR | 79.55% |
| 2019 Q2 | 100.73 Million SAR | -36.77% |
| 2019 FY | 550.74 Million SAR | -11.23% |
| 2019 Q3 | 174.77 Million SAR | 73.5% |
| 2019 Q4 | 116.87 Million SAR | -33.13% |
| 2019 Q1 | 159.29 Million SAR | 11.84% |
| 2018 Q3 | 114.55 Million SAR | -31.03% |
| 2018 Q1 | 197.31 Million SAR | -4.76% |
| 2018 FY | 620.4 Million SAR | -11.93% |
| 2018 Q4 | 142.43 Million SAR | 24.35% |
| 2018 Q2 | 166.09 Million SAR | -15.82% |
| 2017 Q2 | 156.12 Million SAR | -26.56% |
| 2017 FY | 704.46 Million SAR | -22.53% |
| 2017 Q3 | 128.67 Million SAR | -17.58% |
| 2017 Q1 | 212.57 Million SAR | -13.24% |
| 2017 Q4 | 207.17 Million SAR | 61.0% |
| 2016 Q3 | 170.1 Million SAR | -29.72% |
| 2016 Q1 | 252.21 Million SAR | -4.46% |
| 2016 FY | 909.38 Million SAR | 9.29% |
| 2016 Q2 | 242.03 Million SAR | -4.04% |
| 2016 Q4 | 245.02 Million SAR | 44.04% |
| 2015 Q2 | 210.94 Million SAR | -6.6% |
| 2015 Q1 | 225.85 Million SAR | -13.2% |
| 2015 Q3 | 131.31 Million SAR | -37.75% |
| 2015 FY | 832.1 Million SAR | 4.73% |
| 2015 Q4 | 263.97 Million SAR | 101.02% |
| 2014 Q4 | 260.21 Million SAR | 93.54% |
| 2014 Q3 | 134.45 Million SAR | -30.5% |
| 2014 Q2 | 193.45 Million SAR | -6.28% |
| 2014 Q1 | 206.41 Million SAR | -7.84% |
| 2014 FY | 794.53 Million SAR | 13.26% |
| 2013 Q1 | 184.62 Million SAR | -32.35% |
| 2013 Q3 | 115.47 Million SAR | -35.53% |
| 2013 Q4 | 223.97 Million SAR | 93.96% |
| 2013 FY | 701.52 Million SAR | 3.12% |
| 2013 Q2 | 179.11 Million SAR | -2.98% |
| 2012 Q4 | 272.9 Million SAR | 140.92% |
| 2012 FY | 680.31 Million SAR | 21.36% |
| 2012 Q3 | 113.28 Million SAR | 0.0% |
| 2011 FY | 560.56 Million SAR | 15.29% |
| 2010 FY | 486.22 Million SAR | 16.22% |
| 2009 FY | 418.37 Million SAR | 15.8% |
| 2008 FY | 361.28 Million SAR | 11.08% |
| 2007 FY | 325.23 Million SAR | 5.45% |
| 2006 FY | 308.41 Million SAR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 703.81 Million SAR | -0.606% |